APA (7th ed.) Citation

Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., . . . Sato, K. (2020). SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant. Cell reports (Cambridge), 32(12), 108185. https://doi.org/10.1016/j.celrep.2020.108185

Chicago Style (17th ed.) Citation

Konno, Yoriyuki, et al. "SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant." Cell Reports (Cambridge) 32, no. 12 (2020): 108185. https://doi.org/10.1016/j.celrep.2020.108185.

MLA (9th ed.) Citation

Konno, Yoriyuki, et al. "SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant." Cell Reports (Cambridge), vol. 32, no. 12, 2020, p. 108185, https://doi.org/10.1016/j.celrep.2020.108185.